Background {#Sec1}
==========

Rheumatoid arthritis (RA) is a common chronic inflammatory autoimmune disease characterized by significant disability and early mortality. RA affects \~1% of the adults worldwide \[[@CR1]\]. Although its etiology has not been determined, RA has been regarded as a complex autoimmune disorder characterized by a chronic T-cell response. So, genes involved in T-cell response regulation might be important determinants of RA susceptibility.

The cytotoxic T-lymphocyte antigen 4 (CTLA-4) is an inhibitory receptor predominantly expressed on the activated and regulatory T lymphocytes \[[@CR2]\]. It plays an important role in regulating T-cell activation. Several studies have documented that polymorphism of CTLA-4 A49G have remarkable effects on the susceptibility to autoimmunity \[[@CR3]\]. A49G (rs231775) polymorphism, located in the first exon region of CTLA-4 gene, was identified as a functional single nucleotide polymorphism with a A to G change. This polymorphism has been shown to be associated with the susceptibility of diverse diseases \[[@CR4]-[@CR8]\], including RA. The results of previous reports on the possible association of CTLA-4 A49G polymorphism with RA risk remain controversial and ambiguous. To our knowledge, the issue of whether CTLA-4 A49G polymorphism can increase RA risk remains largely uncertain. A comprehensive meta-analysis can provide a reliable estimate in genetic association studies. In this work, we conducted a quantitative meta-analyses that increased statistical power to derive a more precise estimation of the relationship.

Methods {#Sec2}
=======

Study identification and selection {#Sec3}
----------------------------------

A systematic literature search was carried out in the PubMed, IS Web and Chinese National Knowledge Infrastructure (CNKI) database with the terms of "CTLA-4", "rheumatoid arthritis", "polymorphism", "variation". Two investigators independently screened the information including the titles, abstracts and full texts to determine inclusion carefully. No language restrictions were used in our literature search.

Data extraction {#Sec4}
---------------

The following inclusion criteria were used to select related literatures for the meta-analysis: (1) studies about the association between CTLA-4 A49G polymorphism and RA risk; (2) a case-controlled RA study of CTLA-4 A49G polymorphism with complete genotype distribution data; (3) studies on sufficient data and the original data from case--control studies. The following information were extracted from included studies: first author, year of publication, original country, ethnicity of the sample and genotype distributions.

Statistical analysis {#Sec5}
--------------------

The pooled odds ratios (ORs) with the corresponding 95% confidence intervals (95% CI) were used to evaluate the strength of association between the polymorphism of CTLA-4 A49G and RA risk. Four models were estimated: the co-dominant model (GG *vs.* AA, GA *vs.* AA), dominant model (GA + GG *vs.* AA) and recessive model (GG *vs.* GA + AA), respectively. Subgroup analyses were performed by ethnicity.

At first, we evaluated the HWE in the controls for each study using chi-square and a P \< 0.05 was considered as significant disequilibrium. Statistical heterogeneity among the studies was gauged by the Chi-square based on Q-test. A P value greater than 0.1 for the Q-test indicates no significant heterogeneity existing among studies, and the pooled OR estimation was performed using the fixed-effects model (the Mantel-Haenszel method). Otherwise, the random-effects model (DerSimonian and Laird method) was used. Potential publication bias of literatures was analyzed through the Egger's linear regression test with a funnel plot. All statistical analyses were performed with STATA version 11.0 (Stata Corporation, College Station, TX). All the *P* values were calculated using a two-sided test and *P* \< 0.05 were considered as statistically significant.

Results {#Sec6}
=======

Study characteristics {#Sec7}
---------------------

A total of xx articles were retrieve after the first search in various databases. After literature selection, 43 studies about the association of CTLA-4 A49G polymorphism with RA risk were identified and screened for data retrieval. Among which, 16 studies were irrelevant. At last, a total of 27 eligible independent case--control studies in 24 articles were included \[[@CR9]-[@CR33]\]. The characteristics of selected studies are summarized in Table [1](#Tab1){ref-type="table"}. All of the studies indicated that the genotypic distribution of the controls was consistent with Hardy-Weinberg equilibrium.Table 1**Main characteristics of studies included in our workFirst authorYearLocationEthnicityCase/controlsHWEGGGAAA**Seidl1998GermanyCaucasian37/68138/21083/1790.88Matsushita1999JapanAsian200/56199/7262/220.98Gonzalez-Escribano1999SpainCaucasian10/3063/10365/1720.06Barton2000SpainCaucasian14/1257/7065/620.44Yanagawa2000JapanAsian29/7850/886/340.56Hadj2001TunisiaAfrican23/6827/6210/200.33Milicic2001UKCaucasian63/73223/213135/1660.94Lee2002KoreaAsian41/4935/2910/80.49Vaidya2002UKCaucasian20/4565/15838/1460.97Lee2003ChinaAsian103/8567/10016/180.32Liu2004TaiwanAsian14/2142/509/100.07Barton2004UKCaucasian34/2955/6843/590.49Lei2005ChinaAsian148/86138/12540/390.84Takeuchi2006JapanAsian49/4439/4912/110.88Suppiah2006UKCaucasian40/92144/24192/1420.85Tsukahara2008JapanAsian636/181668/194186/730.23Walker2009CanadaCaucasian177/179554/576409/4930.87Munoz-Valle2010MexicoMexican42/34102/8255/830.22Plant (F)2010FranceCaucasian96/15315/75273/720.77Plant (Ge)2010GermanyCaucasian37/94111/8372/830.44Plant (Gr)2010GreeceCaucasian26/33133/107113/1470.15Plant (U)2010UKCaucasian146/410451/1255407/9940.91Benhatchi2011SlovakiaCaucasian6/533/2518/210.82Rocha2011BrailCaucasian9/329/1532/120.86Tang2013ChinaAsian652/474642/535195/1910.154Alfadhli2013KuwaitAsian10/1430/8674/1820.65Liu2013ChinaAsian77/130111/12525/480.16

Quantitative synthesis {#Sec8}
----------------------

All of the main results of the meta-analysis were shown in Table [2](#Tab2){ref-type="table"}. Overall, significant associations between CTLA-4 A49G polymorphism and RA risk was found (GG *vs.* AA: OR = 1.13, 95% CI = 1.03--1.23; GA *vs.* AA: OR = 1.19, 95% CI = 1.07--1.33; GA + GG *vs.* AA: OR = 1.18, 95% CI = 1.07--1.29) (Figure [1](#Fig1){ref-type="fig"}). Next, we performed a further analysis on data stratified by ethnicity groups with the attempt to search for possible factors that might impact the results. In the subgroup analysis by ethnicity, evidences of significantly increased risk was also found in both Asian (GG *vs.* AA: OR = 1.34, 95% CI = 1.15--1.55; GA + GG *vs.* AA: OR = 1.24, 95% CI = 1.08--1.41) and Caucasian population (GA *vs.* AA: OR = 1.19, 95% CI = 1.03--1.37; GA + GG *vs.* AA: OR = 1.14, 95% CI = 1.01--1.29) in different genetic models.Table 2**Results of meta-analysis for CTLA-4 A49G polymorphism and RA riskGroupsGG vs AAGA vs AAGA + GG vs AAGG vs GA + AA*P-value*OR (95% CI)*P-value*OR (95% CI)*P-value*OR (95% CI)*P-value*OR (95% CI)**Total0.0091.13 (1.03, 1.23)0.0011.19 (1.07, 1.33)0.0011.18 (1.07, 1.29)0.661.03 (0.91, 1.17)Asians0.0011.34 (1.15, 1.55)0.0831.16 (0.98, 1.37)0.0021.24 (1.08, 1.41)0.0991.14 (0.97, 1.35)Caucasian0.9911.00 (0.89, 1.12)0.0151.19 (1.03, 1.37)0.0421.14 (1.01, 1.29)0.510.93 (0.77, 1.14)Figure 1**Forest plots for the overall association between CTLA-4 A49G polymorphism and RA risk A) GG** ***vs.*** **AA; B) GA** ***vs.*** **AA; C) GA + GG** ***vs.*** **AA; D) GG** ***vs.*** **GA + GG.**

Heterogeneity analysis {#Sec9}
----------------------

Significant heterogeneity existed in all four genetic models (GG *vs.* AA: *P* = 0.016, I^*2*^ = 40.7%; GA *vs.* AA: *P* = 0.01, I^*2*^ = 42.9%; GA + GG *vs.* AA: *P* = 0.027, I^*2*^ = 37.4%; GG *vs.* GA + AA: *P* = 0.00, I^*2*^ = 58.2%). Therefore, the random-effect models were employed in all genetic models.

Sensitivity analyses and publication bias {#Sec10}
-----------------------------------------

Sensitivity analyses were performed to assess whether each individual study can affect the final results by using Begg's test and Egger's test. Neither the Begg's test nor the Egger's test provided any obvious evidences of publication bias (Table [3](#Tab3){ref-type="table"}). The shapes of the funnel plots appeared to be symmetrical in all genetic models (Figure [2](#Fig2){ref-type="fig"}). These results showed that no individual study affected the final results in diverse genetic models using the exclusion method step by step.Table 3**Results of Egger's test and Begg's testComparisonEgger's testBegg's test*t**P*95% CI*Z**P***GG vs AA0.310.76(−0.92, 1.25)0.670.51GA vs AA1.020.32(−0.54, 1.61)0.330.74GA + GG vs AA1.070.29(−0.49, 1.55)0.670.51GG vs GA + AA−0.550.58(−1.62, 0.94)0.080.93Figure 2**Funnel plots for A49G polymorphism of CTLA-4 in RA disease A) GG** ***vs.*** **AA; B) GA** ***vs.*** **AA; C) GA + GG** ***vs.*** **AA; D) GG** ***vs.*** **GA + GG.**

Discussion {#Sec11}
==========

Although many efforts have been devoted for decades, the underlying molecular genetic basis of RA remains largely unknown. Recently, researches in the genetic susceptibility to RA have led to growing attentions to the study of association between gene polymorphisms and RA \[[@CR34]\]. Large and well-designed genotype-phenotype investigations with robust statistical technical are required to detect these mild to moderate associations. Up to date, the association studies have been performed for CTLA-4 A49G polymorphism with respect to several disease susceptibility, such as liver disease, pancreatic cancer, primary biliary cirrhosis, etc. \[[@CR5],[@CR35],[@CR36]\]. It has been realized that CTLA-4 A49G polymorphism play important role in disease disorders.

Several case--control studies have demonstrated inconsistent and even inverse relationship between CTLA-4 A49G polymorphism and RA risk. Until now, there are still no consensus results on the association of CTLA-4 A49G polymorphism and susceptibility of RA. In this work, we conducted a more comprehensive meta-analysis on the CTLA-4 A49G polymorphism and RA. For the overall data, it has been shown that CTLA-4 A49G polymorphism have an elevated association with RA risk. In the subgroup analysis by ethnicity, results suggested that strong evidences support the association between RA risk and CTLA-4 A49G polymorphism in both Asian and Caucasian populations. Previous meta-analyses works have reported that the CTLA-4 A49G polymorphism is associated with RA risk in Asians, but not in Caucasians using limited data \[[@CR37],[@CR38]\]. In our work, we performed an up-dated meta-analyses, and found that A49G polymorphism is associated with RA risk in both Asians and Caucasians.

Many works have been devoted to examine the association between polymorphisms and RA risk \[[@CR39],[@CR40]\]. As we know, genetic polymorphism of biomarkers is the key factor leading to the susceptibility of diseases. Our work suggests that CTLA-4 A49G polymorphism might be a potential clinical marker for RA. Important clinical insights are emerging, and this polymorphism provides new understanding of RA diagnostic advances. We provided useful reference for clinical medical treatment. However, there are still some limitations in our meta-analysis work. First, we were not able to take into account other factors because of lacking the original data, such as alcohol addictive, inflammation and other disease that may influence the association estimates; Second, although all eligible studies were summarized, the total sample size might have not been enough to make a convincing conclusion. So, when we performed stratified analysis of ethnicity, the number of each subgroup was relative smaller.

Conclusions {#Sec12}
===========

Our meta-analyses provided a more comprehensive evidence of the association between CTLA-4 A49G polymorphism and RA risk. The result showed that CTLA-4 A49G polymorphism is associated with susceptibility of RA.
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